Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | NAGENiagen Bioscience, Inc.FY2025 · Dec |
|---|---|
| Revenue | $129.42M |
| Revenue, yoy | +29.9% |
| Net income | $17.38M |
| Net income, yoy | +103.3% |
| Net margin | 13.4% |
| Free cash flow | $21.18M |
| FCF margin | — |
| EPS, diluted | $0.20 |
Add another company.